Claritin and Veletri drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Claritin (loratadine) and Veletri (epoprostenol sodium). Common drug interactions include fluid retention among females and headache among males.

The phase IV clinical study analyzes what interactions people have when they take Claritin and Veletri. It is created by eHealthMe based on reports of 77 people who take the same drugs from the FDA, and is updated regularly.

What is Claritin?

Claritin has active ingredients of loratadine. It is often used in allergies. eHealthMe is studying from 77,315 Claritin users. Check the latest studies of Claritin.

What is Veletri?

Veletri has active ingredients of epoprostenol sodium. eHealthMe is studying from 14,196 Veletri users. Check the latest studies of Veletri.



On Jul, 09, 2026

77 people who take Claritin and Veletri together, and have interactions are studied.

Claritin and Veletri drug interactions.

What are the common drug interactions of Claritin and Veletri, by gender? *:

female:

  1. Fluid retention (an abnormal accumulation of fluid in the blood)
  2. Back pain
  3. Syncope (loss of consciousness with an inability to maintain postural tone)
  4. Drug hypersensitivity
  5. Lip swelling
  6. Pulmonary arterial hypertension (high blood pressure in the arteries of lungs)
  7. Abdominal distension
  8. Nasopharyngitis (inflammation of the nasopharynx)
  9. Pain in extremity
  10. Dizziness

male:

  1. Headache (pain in head)
  2. Pain in jaw
  3. Catheter site swelling
  4. Device occlusion
  5. Emotional distress
  6. Hypoaesthesia (reduced sense of touch or sensation)
  7. International normalised ratio increased
  8. Jugular vein thrombosis (clot in jugular vein)
  9. Nervousness
  10. Pneumonia

What are the common drug interactions of Claritin and Veletri, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Abdominal distension
  2. Headache (pain in head)
  3. Palpitations (feelings or sensations that your heart is pounding or racing)
  4. Vomiting
  5. Nasopharyngitis (inflammation of the nasopharynx)

20-29:

  1. Diplopia (double vision)
  2. Dizziness
  3. Dyspnoea (difficult or laboured respiration)
  4. Headache (pain in head)
  5. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
  6. Loss of consciousness
  7. Refraction disorder (an error in the focusing of light by the eye)
  8. Vision blurred
  9. Visual impairment

30-39:

  1. Diarrhoea
  2. Flushing (the warm, red condition of human skin)
  3. Pain in jaw
  4. Abdominal discomfort
  5. Nausea (feeling of having an urge to vomit)
  6. Cough
  7. Lip swelling
  8. Nasopharyngitis (inflammation of the nasopharynx)
  9. Pain in extremity
  10. Abdominal distension

40-49:

  1. Pain in jaw
  2. Fatigue (feeling of tiredness)
  3. Diarrhoea
  4. Headache (pain in head)
  5. Nausea (feeling of having an urge to vomit)
  6. Flushing (the warm, red condition of human skin)
  7. Dyspnoea (difficult or laboured respiration)
  8. Catheter site haemorrhage (bleeding at catheter site)
  9. Palpitations (feelings or sensations that your heart is pounding or racing)
  10. Hypotension (abnormally low blood pressure)

50-59:

  1. International normalised ratio increased
  2. Jugular vein thrombosis (clot in jugular vein)
  3. Nasopharyngitis (inflammation of the nasopharynx)
  4. Nervousness
  5. Staphylococcal infection (an infection with staphylococcus bacteria)
  6. Staphylococcus test positive
  7. White blood cell disorder
  8. Staphylococcal bacteraemia (a bacterial infection of blood)
  9. Catheter site infection (infection at the site of insertion)
  10. Abdominal pain

60+:

  1. Diarrhoea
  2. Asthenia (weakness)
  3. Cardiac failure
  4. Cough
  5. Hypoxia (low oxygen in tissues)
  6. Pulmonary arterial hypertension (high blood pressure in the arteries of lungs)
  7. Bone pain
  8. Breath sounds
  9. Catheter site inflammation (infection at catheter site)
  10. Catheter site rash

What are the existing conditions these people have? *

  1. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 47 people, 61.04%
  2. Pulmonary Hypertension (increase in blood pressure in the lung artery): 32 people, 41.56%
  3. Nausea (feeling of having an urge to vomit): 6 people, 7.79%
  4. Diarrhea: 6 people, 7.79%

* Approximation only. Some reports may have incomplete information.

Do you take Claritin and Veletri?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Claritin and Veletri:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Claritin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Veletri:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Claritin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Veletri and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on loratadine and epoprostenol sodium (the active ingredients of Claritin and Veletri, respectively), and Claritin and Veletri (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: